BMI-Adjusted PEEP During One-Lung Ventilation in Thoracic Surgery (SIMPLE-PEEP)
Effect of Body Mass Index-Adjusted Positive End-Expiratory Pressure on Respiratory Mechanics During One-Lung Ventilation in Thoracic Surgery
One-lung ventilation (OLV) is required during many thoracic surgical procedures and is associated with reduced functional residual capacity, atelectasis, ventilation-perfusion mismatch, hypoxemia, and potentially ventilator-induced lung injury. Lung-protective ventilation strategies include low tidal volumes, limitation of airway pressures, and positive end-expiratory pressure (PEEP), but the optimal PEEP level during OLV remains uncertain. Fixed PEEP is simple and reproducible but does not account for individual patient characteristics. Body mass index (BMI) is readily available before anesthesia and is associated with respiratory mechanics, making it a pragmatic candidate for simple PEEP individualization.
SIMPLE-PEEP is a prospective, multicenter, pragmatic, open-label, randomized clinical trial including 150 adults undergoing elective pulmonary resection under general anesthesia requiring OLV. Participants will be randomized to either fixed PEEP of 4 cmH2O or BMI-adjusted PEEP calculated as BMI/3 cmH2O. Other key components of lung-protective ventilation will be standardized between groups.
The primary outcome is driving pressure during the first 20 minutes of OLV, assessed at 5, 10, and 20 minutes after OLV initiation. Secondary outcomes include respiratory system compliance and other respiratory mechanics, estimated mechanical power, oxygenation, intraoperative hypoxemia and rescue maneuvers, hemodynamic safety, vasopressor requirements, and exploratory postoperative respiratory outcomes. No investigational medicinal product, additional invasive procedure, or study-specific advanced monitoring is required.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Jesús M Nieves Alonso, MD
- Numéro de téléphone: +34915202540
- E-mail: jesusmna@gmail.com
Lieux d'étude
-
-
Catalonia
-
Barcelona, Catalonia, Espagne, 08036
- Pas encore de recrutement
- Hospital Clinic Barcelona
-
Contact:
- Manuel L López
- E-mail: LOPEZ10@clinic.cat
-
Barcelona, Catalonia, Espagne, 08041
- Pas encore de recrutement
- Hospital de la Santa Creu i Sant Pau
-
Contact:
- Ana P Parera
- E-mail: AParera@santpau.cat
-
-
Madrid
-
Madrid, Madrid, Espagne, 28006
- Recrutement
- Hospital Universitario de La Princesa
-
Contact:
- Jesús M Nieves Alonso, MD
- Numéro de téléphone: +34915202540
- E-mail: jesusmna@gmail.com
-
Madrid, Madrid, Espagne, 28007
- Pas encore de recrutement
- Hospital General Universitario Geogorio Marañón
-
Contact:
- Estrela C Caamaño
- E-mail: estrelacaamano@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 18 years or older.
- Scheduled thoracic surgery for pulmonary resection requiring general anesthesia and one-lung ventilation.
- Written informed consent obtained before any study-specific procedure.
Exclusion Criteria:
- Simultaneous participation in another interventional clinical trial that could interfere with the protocol.
- Severe hemodynamic instability before the start of the procedure, defined as continuous vasopressor infusion or shock of any etiology.
- Severe restrictive lung disease, defined as total lung capacity <50% of predicted or forced vital capacity <50% of predicted.
- Body mass index >45 kg/m2.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Fixed PEEP of 4 cmH2O
|
Fixed PEEP of 4 cmH2O |
|
Expérimental: BMI-adjusted PEEP calculated as BMI/3 cmH2O
|
BMI-adjusted PEEP calculated as BMI/3 cmH2O |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Driving pressure during the primary T2-T4 window
Délai: 20 minutes
|
Driving pressure during the primary T2-T4 window, measured at 5, 10, and 20 minutes after initiation of one-lung ventilation and expressed in cmH2O. In conventional volume-controlled ventilation, driving pressure is calculated as plateau pressure minus applied PEEP. In pressure-regulated volume-targeted/volume-guaranteed modes, driving pressure is calculated as total end-inspiratory pressure minus applied PEEP. |
20 minutes
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Respiratory system compliance
Délai: At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
Respiratory system compliance will be calculated at each applicable time point as tidal volume divided by driving pressure and expressed in mL/cmH2O |
At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
|
Driving pressure at 60 minutes and at the end of one-lung ventilation
Délai: At 60 minutes after initiation of one-lung ventilation, when applicable, and at the end of one-lung ventilation.
|
Driving pressure will be assessed at 60 minutes after initiation of one-lung ventilation, when this time point is applicable, and at the actual end of one-lung ventilation, to evaluate the persistence of the physiological effect of the assigned PEEP strategy. |
At 60 minutes after initiation of one-lung ventilation, when applicable, and at the end of one-lung ventilation.
|
|
Estimated mechanical power during one-lung ventilation
Délai: At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
Ventilatory mechanical power will be estimated from prospectively recorded ventilatory parameters using a prespecified calculation method appropriate to the ventilation mode and expressed in J/min. |
At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.
|
|
Incidence of intraoperative hypoxemia during one-lung ventilation
Délai: From initiation until completion of one-lung ventilation during the surgical procedure on Day 1 (up to 1 day).
|
Intraoperative hypoxemia will be defined as SpO2 <90% sustained for at least 60 seconds during one-lung ventilation with baseline FiO2 0.6, or any episode of SpO2 <90% requiring immediate clinical intervention at the discretion of the attending anesthesiologist. |
From initiation until completion of one-lung ventilation during the surgical procedure on Day 1 (up to 1 day).
|
|
Incidence of major ventilatory rescue
Délai: During the first 20 minutes after initiation of one-lung ventilation on Day 1.
|
Major ventilatory rescue during the first 20 minutes after initiation of one-lung ventilation will be defined as any intervention that substantially modifies the assigned ventilatory strategy or respiratory mechanics, including modification of PEEP from the assigned value, recruitment maneuver, CPAP to the non-ventilated lung, temporary restoration of two-lung ventilation, or protocol interruption for safety reasons. |
During the first 20 minutes after initiation of one-lung ventilation on Day 1.
|
|
Incidence of intraoperative hypotension
Délai: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
Intraoperative hypotension will be defined as mean arterial pressure <65 mmHg sustained for more than 1 minute. |
Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
|
Requirement for intraoperative vasopressor support
Délai: Time Frame: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
Proportion of participants requiring vasopressor administration during the intraoperative period. Vasopressor use will be recorded as a measure of the hemodynamic safety of the assigned PEEP strategy. |
Time Frame: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.
|
|
Incidence of postoperative pulmonary complications
Délai: From the end of surgery until hospital discharge during the index hospitalization (estimated average duration: 3-10 days).
|
Occurrence of at least one prespecified postoperative pulmonary complication, including acute respiratory failure, pneumonia, acute respiratory distress syndrome, atelectasis, pneumothorax, bronchopleural fistula, aspiration pneumonitis, pulmonary embolism, pleural empyema, bronchospasm, pleural effusion, or need for postoperative respiratory support or reintubation for respiratory deterioration. This outcome will be considered exploratory. |
From the end of surgery until hospital discharge during the index hospitalization (estimated average duration: 3-10 days).
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- SIMPLE-PEEP
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .